CEBPA and acute myeloid leukemia: AML (post-BPDCN): *TET2 p.324-325IX fs, *TET2 p.P1915L, CUX1 p.R1214 fs, ATM p.M94V, NCOR1 sa, PHF6 p.K324, RUNX1 p.S141L, CEBPA p.E76fs3, CEBPA p.Y285fs2, RUNX1 p.D198G,